Promoter/Promoter Group of Rane Engine Valve Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Arvind Fashions Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Future Supply Chain Solutions Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Time Technoplast Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Future Consumer Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Navkar Corporation Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Members of the Exchange are hereby informed that the trading in equity shares of Rohit Ferro-Tech Limited (ISIN: INE248H01012) shall be suspended w.e.f. April 7, 2022, pursuant to approval of the resolution plan by the Hon???ble NCLT Kolkata, that existing equity shares of the Company shall stand delisted (at no exit price to existing equity shareholders) without any further act and deed, from the effective date of the Resolution Plan. Further, in terms of the Resolution Plan, the entire existing paid-up equity share capital of the Company will stand extinguished.
In terms of SEBI Circular No. SEBI/HO/CFD/CMDI/CIR/9/2019/140 dated November 21, 2019; we are enclosing herewith relevant disclosures of defaults for the quarter and year ended on March 31, 2022. You are requested to take the above submissions in your records.
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 31-Mar-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg.
Promoter/Promoter Group of Refex Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
